WAM Capital Limited announces record profit. Here's how they did it

WAM Capital Limited (ASX:WAM) has increased its profit to a record $98 million.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Listed investment company (LIC) WAM Capital Limited (ASX: WAM) has today announced an 81.5% increase in net profit after tax to $98 million.

The $1 billion LIC also announced an increase in the final dividend to 7.25 cents per share (cps). Coupled with an interim dividend of 7 cps, the full year dividend comes in at 14.5 cps which is 0.5 cps above last year.

While the headline numbers are indeed impressive and the dividend – which currently equates to a fully franked yield of around 6.3% – will certainly be welcomed by shareholders, of even more interest is how the manager achieved such an astounding return.

Today's results show WAM Capital's investment portfolio achieved a gain of 21.6% for the year ending June 30 2016. That's outperformance of around 20%, compared with a return of just 2% from its benchmark the S&P/ASX All Ordinaries Accumulation Index!

Big Winners

Stocks singled out as top performers were:

It's worth noting however that WAM Capital operates with a diversified portfolio. Currently its single largest position represents 3.8% of the portfolio, while many of its remaining top 20 positions are roughly around 1.5% in size.

The diversified nature of WAM Capital's portfolio, which should imply lower risk, makes the strong gains all the more impressive.

Although it's rare for last year's winners to be next year's top performers, there are two stocks from the above list which (I think) could still be worth a closer look.

Firstly, as I have previously written here, Mayne Pharma has recently agreed to acquire a significant portfolio of FDA approved drugs. This acquisition propels the group into a much larger manufacturer of both generic and branded specialty pharmaceuticals.

Mayne's acquisition has led to a significant upgrade in earnings expectations. According to consensus estimates for financial year 2017, in the past week forecast earnings per share (EPS) have doubled from 315 cps to 617 cps. (source: Reuters)

Secondly, Smartgroup also looks appealing still. The group actually entered a trading halt on Monday morning upon the announcement that the group has agreed to acquire peer Selectus for an initial consideration of $119 million.

The group also took the opportunity to provide the market with updated guidance.

Smartgroup is expecting to report underlying profit growth of 44% for the six months to June 30 2016 and it is forecasting EPS accretion post synergies of 15% to 16% from the Selectus acquisition.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »